Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1995
12/06/1995EP0684820A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
12/06/1995EP0684817A1 Cancer treatment
12/06/1995EP0520021B1 Pharmaceutical compositions
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995EP0444038B1 Conjugates for bone imaging and bone cancer therapy
12/05/1995US5473071 Process for the preparation of fused pyridine compounds
12/05/1995US5473057 Anticarcinogenic agents
12/05/1995US5473055 Antitumor agents; better water solubility, side effect reduction
12/05/1995US5473054 IGF-1 analogs
12/05/1995US5472976 Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical compositions which contain them
12/05/1995US5472962 Antiestrogenic agents
12/05/1995US5472956 Treating lung, breast, colon, ovaries or melanomas
12/05/1995US5472949 N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same
12/05/1995US5472693 Monoclonal antibodies
12/04/1995CA2150421A1 Platinum complex and malignant tumor treating drug containing the same
11/1995
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032191A1 Inhibitors of farnesyl-protein transferase
11/30/1995WO1995032187A1 Novel fused indan derivative and pharmaceutically acceptable salt thereof
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031983A1 Treating conditions with (+)-liarozole
11/30/1995WO1995031982A1 Treating conditions using optically pure(-)-liarozole
11/30/1995WO1995031977A1 Novel potent inducers of terminal differentiation and methods of use thereof
11/30/1995WO1995031971A1 Method for stabilizing duocarmycin derivatives
11/30/1995WO1995031965A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
11/30/1995WO1995030002A3 Enhancing the sensitivity of tumor cells to therapies
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995DE4421391C1 Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression Use of antibodies against T-cells for prolonged immunosuppression
11/30/1995DE4415263C1 Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung Cis- [trans-1,2-Cyclobutanbis (methylamine) -N, N '] - [(2S) -lactato-O · 1 ·, O · 2 ·] -platinum (II) trihydrate (lobaplatin trihydrate), its preparation and medicinal use
11/30/1995CA2190846A1 Inhibitors of farnesyl-protein transferase
11/30/1995CA2190635A1 Method for stabilizing duocarmycin derivatives
11/30/1995CA2190096A1 Treating conditions using optically pure(-)-liarozole
11/29/1995EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/29/1995EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution
11/29/1995EP0683784A1 7,42-bis (o-demethyl) rapamycin
11/29/1995EP0683783A1 Rapamycin derivative process for its preparation and its use
11/29/1995EP0683772A1 Retroviral protease inhibiting compounds
11/29/1995EP0683768A1 Unsymmetrical bis-imides as anticancer agents
11/29/1995EP0683762A1 Acylfulvene analogues as antitumor agents
11/29/1995EP0683760A1 Dehydrogenation processes and equipment therefor
11/29/1995EP0683665A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use
11/29/1995EP0683664A1 Taxol formulation
11/29/1995EP0642586A4 CULTURED -i(TAXUS) TISSUES AS A SOURCE OF TAXOL, RELATED TAXANES AND OTHER NOVEL ANTI-TUMOR/ANTI-VIRAL COMPOUNDS.
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995EP0586523A4 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/29/1995EP0440689B1 Anti-idiotypic antibody induction of antitumor response
11/29/1995EP0412116B1 Detection of neu gene expression and products
11/29/1995CN1112442A Baicaoshengshou oral liquor and its preparation
11/29/1995CN1112420A Orally administerable pharmaceutical formulations
11/29/1995CN1112416A Cosmetic or pharmaceutical compositions consisting of liposomes
11/28/1995US5470962 Oligosialyl-1,2-dialkyl-sn-glycerols and synthetic intermediates for their preparation
11/28/1995US5470960 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470877 Causing carcinoma regression
11/28/1995US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
11/28/1995US5470854 Antiestrogens
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470589 Hardening agent for affected tissues of the digestive system
11/28/1995CA2006821C Substance dc 113 and production thereof
11/28/1995CA1337670C Cell growth inhibitory substance
11/28/1995CA1337651C Pheophorbide derivatives
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995WO1995031213A1 IFN-β LIQUID FORMULATIONS
11/23/1995WO1995031205A1 Sialic acid/fucose based medicaments
11/23/1995WO1995031203A1 Oral liquid alendronate formulations
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995WO1995026981A3 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995CA2578402A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190465A1 Ifn-.beta. liquid formulations
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995CN1112364A Piperazine derivatives and salts thereof
11/22/1995CN1112363A Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
11/22/1995CN1112122A Sulfated-glycolipid derivatives as cell adhesion inhibitors
11/22/1995CN1112117A Imidazole-containing inhibitors of farnesyl protein transferase
11/22/1995CN1112011A Powerful anticancer plaster and its preparing method
11/22/1995CN1111999A Cancer therapy injection
11/21/1995US5468897 Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
1 ... 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 ... 2211